- Home
- TOMZ vs EVAX Comparison
TOMZ vs EVAX Comparison
Compare TOMZ & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- EVAX
- Stock Information
- Founded
- TOMZ 1979
- EVAX 2008
- Country
- TOMZ United States
- EVAX Denmark
- Employees
- TOMZ N/A
- EVAX N/A
- Industry
- TOMZ Diversified Commercial Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOMZ Finance
- EVAX Health Care
- Exchange
- TOMZ Nasdaq
- EVAX Nasdaq
- Market Cap
- TOMZ 20.3M
- EVAX 17.8M
- IPO Year
- TOMZ N/A
- EVAX 2021
- Fundamental
- Price
- TOMZ $0.90
- EVAX $6.79
- Analyst Decision
- TOMZ Strong Buy
- EVAX Strong Buy
- Analyst Count
- TOMZ 1
- EVAX 2
- Target Price
- TOMZ $3.50
- EVAX $11.00
- AVG Volume (30 Days)
- TOMZ 47.6K
- EVAX 4.8M
- Earning Date
- TOMZ 11-07-2025
- EVAX 11-07-2025
- Dividend Yield
- TOMZ N/A
- EVAX N/A
- EPS Growth
- TOMZ N/A
- EVAX N/A
- EPS
- TOMZ N/A
- EVAX N/A
- Revenue
- TOMZ $6,219,036.00
- EVAX $3,176,000.00
- Revenue This Year
- TOMZ $18.31
- EVAX N/A
- Revenue Next Year
- TOMZ $103.30
- EVAX $425.50
- P/E Ratio
- TOMZ N/A
- EVAX N/A
- Revenue Growth
- TOMZ N/A
- EVAX 1042.45
- 52 Week Low
- TOMZ $0.63
- EVAX $1.20
- 52 Week High
- TOMZ $1.50
- EVAX $15.50
- Technical
- Relative Strength Index (RSI)
- TOMZ 40.73
- EVAX 55.15
- Support Level
- TOMZ $0.93
- EVAX $5.81
- Resistance Level
- TOMZ $0.98
- EVAX $12.15
- Average True Range (ATR)
- TOMZ 0.04
- EVAX 1.35
- MACD
- TOMZ -0.01
- EVAX 0.29
- Stochastic Oscillator
- TOMZ 4.43
- EVAX 36.57
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.